Chemical Messenger News and Research

RSS

GW to participate in a clinical trial for investigational COVID-19 vaccine

The George Washington University today announced that it will participate in a clinical trial for an investigational COVID-19 vaccine.

27 Jul 2020

Problems in how the brain recognizes and processes novel information underlie psychosis

Problems in how the brain recognizes and processes novel information lie at the root of psychosis, researchers from the University of Cambridge and King's College London have found.

23 Jun 2020

Mutated ATP1B gene a risk factor for Parkinson’s

The brain consists of about 100 billion neurons that form a complex and interconnected network in our brain, allowing us to generate complex thought patterns and actions. These neurons or nerve cells are the functional units of the nervous system that process and transmit information around the body. Neurodegenerative diseases develop with the progressive loss of these neurons.

14 Apr 2020

Future drugs aimed at halting cell-inactivation process may help prevent Parkinson's disease

In neurodegenerative conditions like Parkinson's disease, a specific group of neurons start to die one by one, causing movement problems and other symptoms. Scientists have long focused on finding out why these neurons die. Now it turns out, they might not even be dead.

11 Nov 2019

Scientists use patient-derived neurons to develop new treatment strategy for Parkinson's disease

Northwestern Medicine scientists have used patient-derived neurons to develop and test a new strategy to treat Parkinson's disease by mitigating the effects of harmful genetic mutations, as detailed in a study published today (Oct. 16) in Science Translational Medicine.

16 Oct 2019

Serotonin and anti-depressants can have a major effect on the gut's microbiota

A new study in mice led by UCLA biologists strongly suggests that serotonin and drugs that target serotonin, such as anti-depressants, can have a major effect on the gut's microbiota -- the 100 trillion or so bacteria and other microbes that live in the human body's intestines.

6 Sep 2019

Johns Hopkins researchers reveal why deep brain stimulation improves Parkinson’s symptoms

In a new study of seven people with Parkinson’s disease, Johns Hopkins Medicine researchers report evidence that deep brain stimulation using electrical impulses jumpstarts the nerve cells that produce the chemical messenger dopamine to reduce tremors and muscle rigidity that are the hallmark of Parkinson’s disease, and increases feelings of well-being.

From Johns Hopkins Medicine 21 Aug 2019

Evidence shows ketamine is not opioid and can treat depression easily

Ketamine’s reputation as an antidepressant is restored; it’s not an opioid.

From Johns Hopkins Medicine 1 Aug 2019

Scientists uncover how airborne particles can exaggerate airway inflammation

An international team of scientists have observed a previously unclear inflammatory mechanism caused by airborne particles that can worsen asthma symptoms, it has been reported in Toxicological Sciences.

25 Jul 2019

Common medications can masquerade as dementia in seniors

By all accounts the woman, in her late 60s, appeared to have severe dementia. She was largely incoherent. Her short-term memory was terrible. She couldn't focus on questions that medical professionals asked her.

18 Jul 2019

Scientists identify potential target for Parkinson's treatment

An international research team led by scientists at the University of Alabama at Birmingham has identified a potential target for therapeutics that might help slow the progression of Parkinson's disease.

12 Jun 2019

Alzheimer's therapy may be effective in treating individuals addicted to opioids

Clinical trial results reveal that a medication used to treat Alzheimer's disease may also be an effective therapy for individuals addicted to opioids. The findings are published in The American Journal on Addictions.

6 Jun 2019

New quantum material effectively detects early signs of neurological diseases

What if the brain could detect its own disease? Researchers have been trying to create a material that "thinks" like the brain does, which would be more sensitive to early signs of neurological diseases such as Parkinson's.

11 Apr 2019

Purdue engineers develop tiny glutamate sensors for spinal cord injuries

Your chances of getting a nasty migraine increase following a spinal cord injury, thanks to a chemical messenger in the brain that spikes to toxic levels, past studies have suggested.

28 Mar 2019

Researchers capture altered brain activity patterns of Parkinson's in mice

The tell-tale tremors of Parkinson's disease emerge from abnormal activity in a brain region crucial for voluntary movement.

19 Feb 2019

UTSA researchers reveal important insight into cocaine addiction

Researchers at The University of Texas at San Antonio have revealed significant insight into cocaine addiction, a phenomenon which has grown significantly in the United States since 2015.

10 Jan 2019

Cocaine-addicted rats show long-lasting increases in number of orexin neurons

A study in cocaine-addicted rats reports long-lasting increases in the number of neurons that produce orexin—a chemical messenger important for sleep and appetite—that may be at the root of the addiction.

12 Sep 2018

TGHRI scientists detail role of insulin as a boost to the immune system

The role of insulin as a boost to the immune system to improve its ability to fight infection has been detailed for the first time by Toronto General Hospital Research Institute scientists.

30 Aug 2018

Study: Mice that lack certain brain receptor get attracted to situations associated with discomfort

The brains of both humans and other animals have circuits that connect powerful impressions from the senses to positive or negative feelings - a function that is necessary for survival.

3 Jul 2018

Cancerous cells in aggressive childhood brain tumor work together to infiltrate the brain, shows study

Scientists have discovered that cancerous cells in an aggressive type of childhood brain tumor work together to infiltrate the brain, and this finding could ultimately lead to much needed new treatments, according to a new study published in Nature Medicine today (Monday).

2 Jul 2018